CONCURSO DE LOGÓTIPOS · tog ther w tog w can tog ther ther w can can together we can together we can
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
description
Transcript of Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 1: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/1.jpg)
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 2: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/2.jpg)
Baseline characteristics of statin studies with paired-comparisons
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 3: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/3.jpg)
Comparisons of the lipid lowering effect of different statins: LDL
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 4: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/4.jpg)
Comparisons of the lipid lowering effect of different statins: HDL
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 5: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/5.jpg)
Comparisons of the lipid lowering effect of different statins: TG
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 6: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/6.jpg)
Low density lipoprotein (LDL) reduction (%) of different statins in different doses
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 7: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/7.jpg)
Weighted mean difference (WMD) with 95% confidence interval (CI) of different statins at equivalent dose
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 8: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/8.jpg)
Effects on cardiovascular events
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 9: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/9.jpg)
Incidence of specific adverse effects (%)
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51
![Page 10: Weng TC, et al. J Clin Pharm Ther 2010;35:139-51](https://reader036.fdocuments.in/reader036/viewer/2022062305/5681684b550346895dde3f8b/html5/thumbnails/10.jpg)
Flow chart of the article selection
Weng TC, et al. J Clin Pharm Ther 2010;35:139-51